European drugmakers fall after Trump raises stakes over US drug price cuts

Novo Nordisk Shares Hit 4-Year Low, Trump Urges US Drug Price Cuts

European drugmaker shares slip as Trump pressures pharma CEOs to cut U.S. prices By Investing.com

European drugmaker shares slip as Trump pressures pharma CEOs to cut U.S. prices

European drugmakers fall after Trump raises stakes over US drug price cuts

Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States, months after signing a sweeping executive order aimed at lowering prices.

European Midday Briefing : Stocks Fall as Trump Raises Tariffs on Dozens of Nations

MARKET WRAPS Stocks: European stocks fell Friday, led by losses in the healthcare and insurance sectors , after Trump announced steeper tariffs against dozens of countries but delayed their... -August 01, 2025 at 04:55 am EDT MarketScreener

Trump pressures pharma giants over prices, including Novartis CEO Vasant Narasimhan

HighlightsU.S. President Donald Trump writes directly to 17 global pharma CEOsIndian American Vasant Narasimhan, CEO of Novartis, among those addressedCompanies given until 29 September 2025 to match U.S. drug prices with Europe and other developed nationsTrump administration demands urgent reform of what it calls “abusive pricing practices”Letter outlines four specific actions, including global price parity and redirecting overseas profitsIn a …

Pharma stocks suffer as Trump demands prescription slash

Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for American consumers. Trump’s threat against pharmaceuticals has given healthcare sector investors “a dose of the blues” after his letter to various company bosses. It outlined that they should either cut US prescription prices or face a tariff crackdown. Russ Mould, investment director at AJ Bell, said: “Widespread share price dec…